Duyuru • Apr 17
Evonik Industries AG, Annual General Meeting, Jun 03, 2026 Evonik Industries AG, Annual General Meeting, Jun 03, 2026, at 10:00 W. Europe Standard Time. Duyuru • Feb 06
Evonik Industries AG announces Annual dividend, payable on June 08, 2026 Evonik Industries AG announced Annual dividend of EUR 1.0000 per share payable on June 08, 2026, ex-date on June 04, 2026 and record date on June 05, 2026. Duyuru • Oct 06
Evonik Industries AG to Report Q4, 2025 Results on Mar 04, 2026 Evonik Industries AG announced that they will report Q4, 2025 results on Mar 04, 2026 Duyuru • Sep 26
Evonik Industries AG Provides Earnings Guidance for the Third Quarter of 2025 Evonik Industries AG provided earnings guidance for the third quarter of 2025. The company expects revenue to be around €3.4 billion in the third quarter of 2025, compared to €3.8 billion in third quarter of 2024. Duyuru • Mar 06
Evonik Industries AG announces Annual dividend, payable on June 02, 2025 Evonik Industries AG announced Annual dividend of EUR 1.1700 per share payable on June 02, 2025, ex-date on May 29, 2025 and record date on May 30, 2025. Reported Earnings • Nov 07
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: EPS: €0.48 (up from €0.21 loss in 3Q 2023). Revenue: €3.83b (up 1.6% from 3Q 2023). Net income: €223.0m (up €319.0m from 3Q 2023). Profit margin: 5.8% (up from net loss in 3Q 2023). Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 12%. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance. Duyuru • Sep 20
Evonik Industries AG to Report Q1, 2025 Results on May 12, 2025 Evonik Industries AG announced that they will report Q1, 2025 results on May 12, 2025 Reported Earnings • Aug 02
Second quarter 2024 earnings released: €0.01 loss per share (vs €0.58 loss in 2Q 2023) Second quarter 2024 results: €0.01 loss per share (improved from €0.58 loss in 2Q 2023). Revenue: €3.93b (up 1.1% from 2Q 2023). Net loss: €5.00m (loss narrowed 98% from 2Q 2023). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance. Upcoming Dividend • May 29
Upcoming dividend of €1.17 per share Eligible shareholders must have bought the stock before 05 June 2024. Payment date: 07 June 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.1%). Reported Earnings • May 09
First quarter 2024 earnings released: EPS: €0.33 (vs €0.10 in 1Q 2023) First quarter 2024 results: EPS: €0.33 (up from €0.10 in 1Q 2023). Revenue: €3.80b (down 5.2% from 1Q 2023). Net income: €156.0m (up 232% from 1Q 2023). Profit margin: 4.1% (up from 1.2% in 1Q 2023). Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 64 percentage points per year, which is a significant difference in performance. Reported Earnings • Mar 05
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: €1.00 loss per share (down from €1.16 profit in FY 2022). Revenue: €15.3b (down 17% from FY 2022). Net loss: €465.0m (down 186% from profit in FY 2022). Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) also missed analyst estimates by 42%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings. Duyuru • Mar 05
International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik. International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik on March 4, 2024. The business to be sold generated sales of €892 million in 2023, with adjusted EBITDA in the mid double-digit million euro range. The final transfer of the business is planned for mid-2024 following approval by the relevant competition authorities. Duyuru • Jan 16
Lanxess Reportedly Seeks to Sell Polyurethane Ops LANXESS Aktiengesellschaft (XTRA:LXS) has initiated a process to sell its polyurethane business, which could be valued at between EUR 500 million (USD 547.2 million) and EUR 600 million, German paper Handelsblatt reported on January 15, 2024. The company has engaged Deutsche Bank to search for a buyer, Handelsblatt said, citing people familiar with the matter. Chemical companies such as Evonik Industries AG (XTRA:EVK), Stockmeier, or Plixxent, are considered possible interested parties. With the sale, Lanxess aims to completely exit the plastics market as the company has transformed into a producer of ingredients for food, cosmetics, and pharmaceuticals. Reported Earnings • Nov 08
Third quarter 2023 earnings released: €0.21 loss per share (vs €0.46 profit in 3Q 2022) Third quarter 2023 results: €0.21 loss per share (down from €0.46 profit in 3Q 2022). Revenue: €3.77b (down 23% from 3Q 2022). Net loss: €96.0m (down 145% from profit in 3Q 2022). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 11
Second quarter 2023 earnings: EPS and revenues miss analyst expectations Second quarter 2023 results: €0.58 loss per share (down from €0.64 profit in 2Q 2022). Revenue: €3.89b (down 19% from 2Q 2022). Net loss: €270.0m (down 191% from profit in 2Q 2022). Revenue missed analyst estimates by 5.6%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Duyuru • Jul 12
Evonik Industries AG Revises Financial Guidance for the Full Year 2023 Evonik Industries AG revised financial guidance for the full year 2023. The sales outlook is adjusted to a range between EUR 14 billion and EUR 16 billion (previously: EUR 17 billion to EUR 19 billion). Duyuru • Jun 09
RAG Stiftung Not in Hurry to Cut Evonik Stake RAG-Stiftung is not in a hurry to reduce its stake in chemicals firm Evonik Industries AG (XTRA:EVK) as the foundation is not under financial pressure, RAG chairman Bernd Toenjes said at a press conference as quotes by German paper Frankfurter Allgemeine Zeitung (FAZ). RAG Stiftung, which owns 54.9% in the chemicals company, plans to cut its stake to a blocking minority in the future. The shareholding may fall below the majority threshold soon. According to Toenjes, a convertible bond is due in 2024, providing an opportunity to reach 50% by the end of 2024. For the moment, Evonik remains one of the most important assets for RAG Stiftung. Upcoming Dividend • May 25
Upcoming dividend of €1.17 per share at 5.9% yield Eligible shareholders must have bought the stock before 01 June 2023. Payment date: 05 June 2023. The company is paying out more than 100% of its profits and is paying out 81% of its cash flow. Trailing yield: 5.9%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.7%). Reported Earnings • May 10
First quarter 2023 earnings released: EPS: €0.10 (vs €0.67 in 1Q 2022) First quarter 2023 results: EPS: €0.10 (down from €0.67 in 1Q 2022). Revenue: €4.01b (down 11% from 1Q 2022). Net income: €47.0m (down 85% from 1Q 2022). Profit margin: 1.2% (down from 7.0% in 1Q 2022). Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 2.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Reported Earnings • Mar 03
Full year 2022 earnings: EPS misses analyst expectations Full year 2022 results: EPS: €1.16 (down from €1.61 in FY 2021). Revenue: €18.5b (up 24% from FY 2021). Net income: €539.0m (down 28% from FY 2021). Profit margin: 2.9% (down from 5.0% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 40%. Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 2.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 10
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Third quarter 2022 results: EPS: €0.46 (down from €0.49 in 3Q 2021). Revenue: €4.88b (up 26% from 3Q 2021). Net income: €214.0m (down 7.4% from 3Q 2021). Profit margin: 4.4% (down from 6.0% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 8.5%. Earnings per share (EPS) also surpassed analyst estimates by 5.1%. Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 11
Second quarter 2022 earnings: EPS and revenues exceed analyst expectations Second quarter 2022 results: EPS: €0.64 (up from €0.48 in 2Q 2021). Revenue: €4.77b (up 31% from 2Q 2021). Net income: €297.0m (up 34% from 2Q 2021). Profit margin: 6.2% (up from 6.1% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 6.7%. Earnings per share (EPS) also surpassed analyst estimates by 17%. Over the next year, revenue is expected to shrink by 1.9% compared to a 3.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Upcoming Dividend • May 19
Upcoming dividend of €1.17 per share Eligible shareholders must have bought the stock before 26 May 2022. Payment date: 31 May 2022. Payout ratio is a comfortable 63% and this is well supported by cash flows. Trailing yield: 4.5%. Within top quartile of German dividend payers (4.4%). Lower than average of industry peers (5.0%). Reported Earnings • May 07
First quarter 2022 earnings: EPS exceeds analyst expectations First quarter 2022 results: EPS: €0.67 (up from €0.41 in 1Q 2021). Revenue: €4.50b (up 34% from 1Q 2021). Net income: €314.0m (up 63% from 1Q 2021). Profit margin: 7.0% (up from 5.7% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 23%. Over the next year, revenue is forecast to grow 2.1%, compared to a 6.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Reported Earnings • Mar 05
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2021 results: EPS: €1.61 (up from €1.05 in FY 2020). Revenue: €15.0b (up 23% from FY 2020). Net income: €748.0m (up 53% from FY 2020). Profit margin: 5.0% (up from 4.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) missed analyst estimates by 6.5%. Over the next year, revenue is forecast to grow 2.9%, compared to a 5.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has fallen by 1% per year. Duyuru • Mar 04
Evonik Industries AG to Report Q4, 2022 Results on Mar 02, 2023 Evonik Industries AG announced that they will report Q4, 2022 results on Mar 02, 2023 Reported Earnings • Nov 06
Third quarter 2021 earnings released: EPS €0.49 (vs €0.32 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €3.87b (up 33% from 3Q 2020). Net income: €231.0m (up 55% from 3Q 2020). Profit margin: 6.0% (up from 5.1% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Reported Earnings • Aug 06
Second quarter 2021 earnings released: EPS €0.48 (vs €0.26 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €3.64b (up 29% from 2Q 2020). Net income: €221.0m (up 77% from 2Q 2020). Profit margin: 6.1% (up from 4.4% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Upcoming Dividend • May 27
Upcoming dividend of €1.15 per share Eligible shareholders must have bought the stock before 03 June 2021. Payment date: 08 June 2021. Trailing yield: 3.9%. Within top quartile of German dividend payers (3.2%). In line with average of industry peers (3.6%). Reported Earnings • May 08
First quarter 2021 earnings released: EPS €0.41 (vs €0.29 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €3.36b (up 3.5% from 1Q 2020). Net income: €193.0m (up 42% from 1Q 2020). Profit margin: 5.7% (up from 4.2% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Reported Earnings • Mar 05
Full year 2020 earnings released The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €12.2b (down 6.9% from FY 2019). Net income: €489.0m (down 35% from FY 2019). Profit margin: 4.0% (down from 5.7% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Analyst Estimate Surprise Post Earnings • Mar 05
Revenue beats expectations, earnings disappoint Revenue exceeded analyst estimates by 0.3%. Earnings per share (EPS) missed analyst estimates by 14%. Over the next year, revenue is forecast to grow 5.8%, compared to a 5.4% growth forecast for the Chemicals industry in Germany. Is New 90 Day High Low • Feb 18
New 90-day high: €27.99 The company is up 18% from its price of €23.64 on 19 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €53.10 per share. Is New 90 Day High Low • Jan 29
New 90-day high: €27.48 The company is up 32% from its price of €20.82 on 30 October 2020. The German market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 29% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €53.29 per share. Is New 90 Day High Low • Jan 07
New 90-day high: €27.31 The company is up 17% from its price of €23.42 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €52.71 per share. Is New 90 Day High Low • Dec 16
New 90-day high: €26.64 The company is up 14% from its price of €23.29 on 17 September 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €44.77 per share. Is New 90 Day High Low • Nov 24
New 90-day high: €25.02 The company is up 1.0% from its price of €24.76 on 26 August 2020. The German market is also up 1.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €39.90 per share. Analyst Estimate Surprise Post Earnings • Nov 05
Revenue and earnings beat expectations Revenue exceeded analyst estimates by 0.1%. Earnings per share (EPS) also surpassed analyst estimates by 3.3%. Over the next year, revenue is forecast to grow 3.9%, compared to a 2.3% growth forecast for the Chemicals industry in Germany. Reported Earnings • Nov 05
Third quarter 2020 earnings released: EPS €0.32 The company reported a soft third quarter result with weaker earnings and revenues, although profit margins were improved. Third quarter 2020 results: Revenue: €2.92b (down 9.7% from 3Q 2019). Net income: €149.0m (down 2.6% from 3Q 2019). Profit margin: 5.1% (up from 4.7% in 3Q 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings. Is New 90 Day High Low • Oct 21
New 90-day low: €21.91 The company is down 12% from its price of €24.76 on 23 July 2020. The German market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €36.51 per share. Is New 90 Day High Low • Sep 24
New 90-day low: €22.40 The company is down 2.0% from its price of €22.95 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €36.43 per share. 
